← All organizations
Highest phase reached
Phase 3
First clinical trial
Sep 3, 2019Last known activity
Dec 31, 2025
Timeline
2010s
- Jun 1, 2018
Keymed Biosciences Co.Ltd— Founded
Drugs by trial phase (15 distinct, 65 trials)
Phase 3 (3 own, 0 via acquisition)
Phase 1 (5 own, 0 via acquisition)
Other trials (1 own, 0 via acquisition)
Recent trials (50)
- NCT07292688Lead sponsorPhase 1Dec 31, 2025
- NCT07230483Lead sponsorPhase 2Dec 31, 2025
- NCT07175493Lead sponsorPhase 1/Phase 2Oct 31, 2025
- NCT07106372Lead sponsorPhase 3Sep 30, 2025
- NCT07181239Lead sponsorPhase 3Sep 30, 2025
- NCT07175506Lead sponsorPhase 1Sep 30, 2025
- NCT07166211Lead sponsorPhase 2Sep 15, 2025
- NCT07011524Lead sponsorPhase 2Aug 19, 2025
- NCT07039578Lead sponsorPhase 2Jul 25, 2025
- NCT07040072CollaboratorPhase 1Jun 30, 2025
- NCT07019779Lead sponsorPhase 1/Phase 2Jun 27, 2025
- NCT06980142Lead sponsorPhase 2Jun 20, 2025
- NCT06947980Lead sponsorPhase 2Jun 19, 2025
- NCT06956196Lead sponsorPhase 3May 31, 2025
- NCT06930612Lead sponsorPhase 2May 16, 2025
Details
- Founded
- Tianfu, CN Jun 1, 2018
- Last known activity
- Dec 31, 2025